Boletín de AInvest
Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
Johnson & Johnson (JNJ) is set to release Q4 earnings later this week with shares up 50% in the past 12 months. The company has a full head of steam, but its stock price may be due for a correction following a massive run-up in 2025. Analysts are tempering expectations for JNJ's future performance, citing a potential downgrade in the coming days.

Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
Comentarios
Aún no hay comentarios